<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="131156">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01956877</url>
  </required_header>
  <id_info>
    <org_study_id>NL45176.068.13</org_study_id>
    <nct_id>NCT01956877</nct_id>
  </id_info>
  <brief_title>Assessment of Normal Values of Esophagogastric Junction (EGJ) Distensibility in Healthy Volunteers</brief_title>
  <official_title>Assessment of Normal Values of Esophagogastric Junction (EGJ) Distensibility in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <authority>Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess normal values of EGJ distensibility in healthy volunteers.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>normal values of esophagogastric junction (EGJ) distensibility (mm2/mmHg) in healthy volunteers as measured with the EndoFLIP device</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>EGJ distensibility as measured by the index of the narrowest cross sectional area (mm2) and the corresponding intrabag pressure (mmHg)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Establishing a cut-off value of EGJ distensibility (mm2/mmHg) based on the 90% percentile distribution of measurements performed in healthy volunteers.</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">15</enrollment>
  <condition>No</condition>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        15 healthy volunteers, age &gt; years
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. No history of gastrointestinal disease, especially gastro-esophageal reflux disease

          2. BMI = 18-30 kg/m²

          3. Caucasian race

          4. Subject signed the informed consent form and is able to adhere to study protocol

        Exclusion Criteria:

          1. Age &lt; 18 years

          2. Previous esophageal or gastric surgery

          3. Co-morbidities (including cardiopulmonary disease, collagen diseases, obesity,
             coagulation disorders and co-morbidity hindering upper gastrointestinal endoscopy)

          4. Patients using anticoagulants

          5. Patients unable to give informed consent

          6. Smoking

          7. History of alcohol abuse or current excessive alcohol consumption (&gt; 2 alcoholic
             beverages per day or &gt; 14 alcoholic beverages per week)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fabienne Smeets, MD</last_name>
    <phone>+31433875021</phone>
    <email>FGM.Smeets@student.maastrichtuniversity.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>José M Conchillo, MD PhD</last_name>
    <phone>+31433875021</phone>
    <email>j.conchillo@mumc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <zip>6229 HX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fabienne Smeets, MD</last_name>
      <phone>+3143-3875021</phone>
      <email>FGM.Smeets@student.maastrichtuniversity.nl</email>
    </contact>
    <investigator>
      <last_name>José M Conchillo, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 30, 2013</lastchanged_date>
  <firstreceived_date>September 16, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
